arrow
A

Atsuo Maemoto

Tokyo Medical University
H指数:23
被引数:1,649

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Clinicopathological features and cancer-specific survival in young patients with ulcerative colitis–associated colorectal neoplasia: a nationwide cohort study in Japan

溃疡性结肠炎相关结直肠新生物年轻患者的临床病理特征及癌症特异性生存率:一项日本全国队列研究

2026-05-190
OA
Background mucosal inflammation affects colorectal cancer prognosis in ulcerative colitis: a nationwide, multicenter study

背景黏膜炎症影响溃疡性结肠炎患者的结直肠癌预后:一项全国多中心研究

2026-02-012
OA
Colitis-associated colorectal neoplasia in ulcerative colitis with primary sclerosing cholangitis: a nationwide study

溃疡性结肠炎合并原发性硬化性胆管炎的结肠炎相关结直肠新生物:一项全国性研究

2026-02-011
PRE
Disease Behaviour Progression and Associated Factors in Crohn's Disease Patients: the Nationwide Inception Cohort Study of Crohn's Disease (iCREST-CD)

克罗恩病患者疾病行为进展及其相关因素:克罗恩病全国起始队列研究(iCREST-CD)

2026-01-010
PRE
Analysis of clinicopathological features and oncological outcomes of ulcerative colitis-associated colorectal cancer based on macroscopic classification

基于大体分型的溃疡性结肠炎相关性结直肠癌的临床病理特征及肿瘤学结局分析

2025-10-290
OA
Real-World Effectiveness and Safety of Vedolizumab in Patients ≥ 70 Versus < 70 Years With Ulcerative Colitis: Multicenter Retrospective Study

溃疡性结肠炎患者中≥70岁与<70岁患者接受维多利珠单抗治疗的实际有效性与安全性:多中心回顾性研究

2025-05-150
OA
Trajectory analyses to optimise third booster COVID-19 vaccination in patients with Inflammatory Bowel Disease: final analyses of the J-COMBAT trial
2025-01-220
PRE
Factors affecting 1-year persistence with vedolizumab for ulcerative colitis: a multicenter, retrospective real-world study

影响维多珠单抗治疗溃疡性结肠炎1年持续性的因素: 一项多中心、回顾性真实世界研究

2025-01-160
OA
EARLY SYMPTOMATIC IMPROVEMENT WITH GUSELKUMAB INDUCTION TREATMENT IN MODERATELYTO SEVERELY ACTIVE ULCERATIVE COLITIS: RESULTS FROM THE PHASE 3 QUASAR INDUCTION STUDY

中度至重度活动性溃疡性结肠炎患者中 guselkumab 诱导治疗的早期症状改善:来自QUASAR诱导研究第3阶段的结果

2024-06-010
PRE
Prognostic impact of tumour location in stage II/III ulcerative colitis-associated colon cancer: subgroup analysis of a nationwide multicentre retrospective study in Japan
2023-11-250
PRE
Trajectory analyses to identify persistently low responders to COVID-19 vaccination in patients with inflammatory bowel disease: a prospective multicentre controlled study, J-COMBAT

确定炎症性肠病患者新型冠状病毒肺炎疫苗接种持续低应答者的轨迹分析: 一项前瞻性多中心对照研究,j-combat

2023-08-102
PRE
Characteristics of adult patients newly diagnosed with Crohn's disease: interim analysis of the nation-wide inception cohort registry study of patients with Crohn's disease in Japan (iCREST-CD) (vol 57, pg 867, 2022)
2023-05-051
OA
Diagnosis and Clinical Features of Perianal Lesions in Newly Diagnosed Crohn's Disease: Subgroup Analysis from Inception Cohort Registry Study of Patients with Crohn's Disease (iCREST-CD)
2023-03-049
OAAI
Anxiety and behavioral changes in Japanese patients with inflammatory bowel disease due to COVID-19 pandemic: a national survey
2023-01-066
OAAI
Effect of Biologics on the Risk of Advanced-Stage Inflammatory Bowel Disease-Associated Intestinal Cancer: A Nationwide Study

生物制剂对晚期炎症性肠病相关肠癌风险的影响: 一项全国性研究

2022-12-147
PRE
Clinical features and oncological outcomes of intestinal cancers associated with ulcerative colitis and Crohn's disease
2022-10-0215
PRE